NASDAQ 100
22.866,97
PKT
+225,08
PKT
+0,99
%
offiziell, realtime
22.906,75
USD
-155,75
USD
-0,68
%
future, verzögert
Werbung
Analysen zu NASDAQ 100-Werten
Datum | Rating | Analyst | |
---|---|---|---|
23.05.12 | Intel outperform | RBC Capital Markets | |
23.05.12 | Analog Devices neutral | UBS AG | |
23.05.12 | Apple overweight | Barclays Capital | |
23.05.12 | Linde buy | Société Générale Group S.A. (SG) | |
22.05.12 | Cognizant overweight | Barclays Capital | |
21.05.12 | The Kraft Heinz Company halten | Hamburger Sparkasse AG (Haspa) | |
21.05.12 | Intuit overweight | Barclays Capital | |
21.05.12 | Intuit kaufen | Die Actien-Börse | |
21.05.12 | Applied Materials outperform | RBC Capital Markets | |
21.05.12 | Ross Stores sector perform | RBC Capital Markets | |
21.05.12 | Dollar Tree outperform | RBC Capital Markets | |
21.05.12 | Autodesk sector perform | RBC Capital Markets | |
18.05.12 | Applied Materials buy | Stifel, Nicolaus & Co., Inc. | |
18.05.12 | CSX overweight | Barclays Capital | |
17.05.12 | Cisco overweight | Barclays Capital | |
16.05.12 | Baker Hughes outperform | RBC Capital Markets | |
16.05.12 | Apple overweight | Barclays Capital | |
15.05.12 | Applied Materials hold | Needham & Company, LLC | |
15.05.12 | NVIDIA equal-weight | Barclays Capital | |
14.05.12 | Xcel Energy outperform | Robert W. Baird & Co. Incorporated | |
14.05.12 | Cisco kaufen | Independent Research GmbH | |
11.05.12 | Charter A outperform | Barrington Research | |
11.05.12 | Apple overweight | Morgan Stanley | |
11.05.12 | Cisco equal-weight | Barclays Capital | |
11.05.12 | Intel buy | UBS AG | |
11.05.12 | Tesla overweight | Barclays Capital | |
11.05.12 | Booking overweight | Barclays Capital | |
11.05.12 | Amazon halten | Der Aktionär | |
11.05.12 | Monster Beverage buy | UBS AG | |
11.05.12 | Monster Beverage buy | Stifel, Nicolaus & Co., Inc. | |
10.05.12 | Cisco buy | UBS AG | |
10.05.12 | Cisco buy | Stifel, Nicolaus & Co., Inc. | |
10.05.12 | Cisco outperform | Oppenheimer & Co. Inc. | |
10.05.12 | Regeneron Pharmaceuticals outperform | RBC Capital Markets | |
10.05.12 | Intel outperform | RBC Capital Markets | |
10.05.12 | Cisco neutral | Sarasin Research | |
10.05.12 | Biogen buy | UBS AG | |
09.05.12 | Analog Devices neutral | UBS AG | |
09.05.12 | Apple overweight | Barclays Capital | |
09.05.12 | Vertex Pharmaceuticals overweight | Barclays Capital |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.